WHO Global Invasive Bacterial Vaccine-Preventable Disease and Rotavirus and Pediatric Diarrhea Surveillance Networks Bulletin, August 2019
WHO publishes new guidelines for the treatment of sleeping sickness
WHO statement on Yemen
Development of a Global Strategy for TB Research and Innovation
Public call for individual patient data on treatment of drug-resistant tuberculosis
WHO Director-General calls for urgent country action to meet UN High-Level Meeting targets in letters to Heads of State
At 1-year mark, we mourn the lives lost to Ebola, and call for solidarity
Invest in eliminating hepatitis
15 million people affected with hepatitis B and C in Pakistan: Government announces ambitious plan to eliminate hepatitis
WHO launches new report on the global tobacco epidemic
WHO’s Data Tool improves Ebola Surveillance, Contact Tracing and Decision Making in Uganda
Statement on governance and oversight of human genome editing
WHO urges countries to invest in eliminating hepatitis
Countries, partners and civil society pledge to scale up engagement of private and unlinked public health providers to close gaps in access to quality TB care at 14th PPM Working Group Meeting in Jakarta, Indonesia
Countries, partners and civil society pledge to scale up engagement of private and unlinked public health providers to close gaps in access to quality TB care
New member of the Primary Registry Network: Lebanese Clinical Trials Registry (LBCTR)
Joint Statement: Accelerating action to end tuberculosis
WHO applauds Rwanda’s Ebola preparedness efforts
Event driven or daily PrEP: ANRS Prévenir study confirms that these two biomedical prevention strategies are very effective and safe
WHO recommends dolutegravir as preferred HIV treatment option in all populations
WHO interim guidance on the use of delamanid in the treatment of MDR-TB
Consultative Meeting on the Strategic Planning for TB Elimination in low burden countries of the Eastern Mediterranean Region, EMRO
A guide to monitoring and evaluation for collaborative TB/HIV activities
Empowering women to break barriers and end TB
Commitment for a TB-Free India
An initiative to extend access to a new TB drug
New additions to the WHO Essential Medicines List related to TB treatment
WHO commends Canada's major contribution to the TB REACH initiative
Latent Tuberculosis Infection (LTBI) Management Session at Wolfheze Workshops 2015
WHO to organise consultative workshop in Addis Ababa, Ethiopia to enhance engagement of nongovernmental and other civil society organisations in the implementation of the End TB Strategy
WHO congratulates President Sampaio for receiving first-ever UN Nelson Mandela Prize
WHO TB Director addresses Young European Scientist (YES) Meeting in Portugal
Report of the 2015 meeting of the WHO Strategic and Technical Advisory Group for TB
WHO issues operational guidance and an eTool to help roll-out systematic screening for active TB
Asia-Pacific nations at the heart of action to end TB
WHO global consultation brings together communities, nongovernmental and other civil society organizations to ramp up efforts to end TB
WHO launches a Global Action Framework for TB Research and creates a new TB research team
World's first child-friendly TB medicines in correct doses
Communities, nongovernmental and other civil society organizations commit to step up action to End TB
Global TB Programme welcomes Declaration on Combating Antimicrobial Resistance and urges inclusion of drug-resistant TB
